180
Participants
Start Date
December 6, 2023
Primary Completion Date
April 13, 2024
Study Completion Date
September 28, 2025
Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp)
1 dose of Tdcp vaccine (0.5ml) on Day 0
23-Valent Pneumococcal Polysaccharide Vaccine(PPV23)
1 dose of PPV23 vaccine (0.5ml) on Day 0
Diphtheria and Tetanus Combined Vaccine, Adsorbed (DT)
1 dose of DT vaccine (0.5ml) on Day 0
Shaanxi Center for Disease Control and Prevention, Xi'an
Lead Sponsor
CanSino Biologics Inc.
INDUSTRY